Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.52 | 0.02 |
mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.44 | 0.02 |
mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.37 | 0.03 |
mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |